BioDuro and AstraZeneca held a signing ceremony in Beijing today to formalize their new collaboration. BioDuro is a CRO based in the US, though its operations are entirely in Beijing. The company offers end-to-end medicinal chemistry services, either from its team of 580 or through affiliations with partners. AstraZeneca produced revenues of more than $31 billion last year from its portfolio of pharmaceuticals. More details...

Stock Symbol: (NYSE: AZN)